ID: MRFR/HC/7026-HCR | 120 Pages | Published By Rahul Gotadki on April 2023
The Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 115.9 Million by 2030 at a CAGR of 11.80%.
Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 115.9 Million by 2030 at a CAGR of 11.80%. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate vital physiological functions of body organs. These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.
There has been an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to increase the growth rate of this Organ-On-a-Chip market in the future further.
The small size of the market is mainly because OOCs have not yet been fully commercialized. They are still in the research and development phase and are being used by a limited number of end-users.
Organ-On-a-Chip Market Influencer
The ability of OOC models to reduce drug development costs drastically and grants by government and non-government entities are the major factors influencing the market growth. It is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this Organ On a Chip market in the future. Grants by government and non-government entities have been the key drivers for the global OOC industry to date. The ability of OOC models to cut drug development costs drastically will be a key market driver in the future.
Moreover, improved drug screening methodologies increased R&D by major players, strategic initiatives and increasing technological advancements are also anticipated to fuel the market growth during the forecast period.
Organ-On-a-Chip Market Drivers
Organ-On-a-Chip Market Segmentation
By Organ Type
Organ-On-a-Chip Market By Region
Organ-On-a-Chip Market Key Players
|Market Size||USD 115.9 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Organ Type, Application and End-User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||CN Bio Innovations Limited (UK), Emulate, Inc. (US), TissUse GmbH (Germany), MIMETAS BV (Netherlands), Hµrel Corporation, Nortis, Inc. (US), InSphero (Switzerland), TARA Biosystems, Inc. (US), Axosim (US), Organovo Holdings Inc. (US), BioIVT (US), HemoShear Therapeutics, LLC (US)|
|Key Market Opportunities||Ability of OOC models to reduce drug development costs drastically and grants by government and non-government entities|
|Key Market Drivers||
Drug testing through organ-on-chip models for drug discovery and application of OOCs in drug toxicology testing as well as in the food & beverage and cosmetic industries
The valuation would be USD 115.9 million by 2030.
The restraints are stringent government rules and complex organ-on-a-chip models.
The lung-on-chip segment has the largest market valuation.
The drug discovery segment has the market upper hand.
The organ-on-a-chip market has a projected CAGR of 53% during the forecast period.